logo-loader

Advaxis

Receive alerts
Market:
NASDAQ
Market Cap:
$9.44 m
Price
0.38 USD
Change
-1.39%
52 weeks high
10.79
52 weeks low
0.21

In brief

Advaxis is a development-stage biotechnology company with the focus on developing cancer vaccines that utilize multiple mechanisms of immunity.